SCHEMBL16670252

SCHEMBL16670252

Cn1nc(C(F)F)c(C(=O)Nc2cccc3c2CCC(C)(C)C3)c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ NPY5R Q15761 1/20 0.35
▸ CACNA1G O43497 7/20 0.35
▸ CACNA1H O95180 7/20 0.35
▸ CACNA1I Q9P0X4 6/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ CACNA1C Q13936 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPT P10636 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15545132 0.88 — —
SCHEMBL16668811 0.79 CYP1A2 (0.34) LMNACYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL16668882 0.77 CYP1A2 (0.35) LMNACYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL15825702 0.77 FABP4 (0.37) L3MBTL1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL15825905 0.76 L3MBTL1 (0.38) LMNANPY5RL3MBTL1KDM4ESMN1; SMN2
Methylamine SCHEMBL27967387 0.74 L3MBTL1 (0.45) LMNANPY5RL3MBTL1KDM4ESMN1; SMN2
SCHEMBL1085493 0.74 CYP1A2 (0.48) LMNACYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL10341113 0.72 CYP1A2 (0.38) LMNACYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL15532491 0.72 L3MBTL1 (0.33) LMNANPY5RL3MBTL1KDM4EALDH1A1
SCHEMBL8613128 0.71 SMN1; SMN2 (0.46) LMNACYP1A2CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9688608-B2 Pyrazole tetrahydronaphthyl carboxamides BAYER CROPSCIENCE AG (DE) 2017-06-27 — — US disclosed
US-20160039741-A1 PYRAZOLE TETRAHYDRONAPHTHYL CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2016-02-11 — — US disclosed
US-9204646-B2 Pyrazole tetrahydronaphthyl carboxamides BAYER CROPSCIENCE AG (DE) 2015-12-08 — — US disclosed
US-20150119242-A1 PYRAZOLE TETRAHYDRONAPHTHYL CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2015-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039741-A1 PYRAZOLE TETRAHYDRONAPHTHYL CARBOXAMIDES TPMT, HDHD5, CBR3 LMNA 3773/4885CYP1A2 267/4885CYP2C9 334/4885
US-20150119242-A1 PYRAZOLE TETRAHYDRONAPHTHYL CARBOXAMIDES TPMT, HDHD5, CBR3 LMNA 3773/4885CYP1A2 267/4885CYP2C9 334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback